Ioannis-Alexios Koumprentziotis

34PUBLICATIONS
43CO-AUTHORS
Gene and molecular therapyTraditional Chinese medicine and treatmentsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsProsthodontics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Oct 16, 2026
Dermatologic Toxicities Associated with Tebentafusp for Uveal Melanoma: A Review of Clinical Trials and Real-World Evidence.

|Oct 16, 2026
Effectiveness and Safety of Pharmacological Treatments for Chronic Inducible Urticaria: A Narrative Synthesis.

|Sep 28, 2026
Dermatologic adverse events associated with Sacituzumab Govitecan: an international retrospective study from the EADV Task Force "Dermatology for Cancer Patients" and pharmacovigilance analysis.

|Sep 27, 2025
Long-Term Outcomes of Guselkumab and Risankizumab for the Management of Moderate-to-Severe Psoriasis in the Elderly: Results from a Real-World Retrospective Study.

Ioannis-Alexios Koumprentziotis, Irene Stefanaki, Eleni Routsi

|Sep 22, 2025
Treatment Resistant Acneiform Eruption in a Young Female: A Diagnostic Pitfall.

Ioannis-Alexios Koumprentziotis, Evdoxia Panou, Antonis Tsimpidakis

|May 16, 2025
Dupilumab for the Treatment of Cutaneous Immune-Related Adverse Events: A Systematic Review.

Ioannis-Alexios Koumprentziotis, Aikaterini Niforou, Antonios Tsimpidakis

Pageof 6

Frequent Collaborators

9 joint publications

Vasiliki Nikolaou

5 joint publications

Electra Nicolaidou

5 joint publications

Natalia Rompoti

5 joint publications

Antonis Tsimpidakis